30506 Federal Register / Vol. 63, No. 107 /Thursday, June 4, 1998 / Notices

ADDENDUM IV.—REGULATION DOCUMENTS PUBLISHED IN THE FEDERAL REGISTER—Continued

Publication

date

FR Vol. 62,

page CFR part(s) File code* Regulation title End of comment period

Effective

date

09/17/97 ....... 48872–

48873

.................... BPD–898–NC ... Medicare and Medicaid Programs; Announcement

of Additional Applications From Hospitals Requesting Waivers for Organ Procurement Service Area.

11/17/97 ....................

09/18/97 ....... 49049 400 409

410 411

412 413

424 440

485 488

489 498

BPD–878–FC ... Medicare Program; Changes to the Hospital Inpatient Prospective Payment Systems and Fiscal

Year 1998 Rates; CORRECTION.

.................... ....................

09/23/97 ....... 49649–

49654

.................... OMC–029–N .... Medicare Program; Solvency Standards for Provider-Sponsored Organizations; Intent To Form

Negotiated Rulemaking Committee.

10/08/97 ....................

09/23/97 ....... 49726 440 MB–071–F ........ Medicaid Program; Coverage of Personal Care

Services; CORRECTION.

.................... ....................

09/24/97 ....... 49937–

49938

473 BPD–453–CN ... Medicare Program; Medicare Appeals of Individual

Claims; CORRECTION.

.................... 06/11/97

Categorization of Food and Drug

Administration-Approved

Investigational Device Exemptions

Under the Food, Drug, and Cosmetic

Act (21 U.S.C. 360c), devices fall into

one of three classes. Also, under the

new categorization process to assist

HCFA, the Food and Drug

Administration assigns each device with

a Food and Drug Administrationapproved investigational device

exemption to one of two categories. To

obtain more information about the

classes or categories, please refer to the

Federal Register notice published on

April 21, 1997 (62 FR 19328).

The following information presents

the device number, category (in this

case, A), and criterion code.

G960082 A1

G970008 A4

G970044 A2

G970058 A2

G970069 A2

G970073 A2

G970088 A2

G970118 A2

G970121 A2

G970128 A1

G970131 A1

G970136 A2

G970147 A1

G970151 A2

G970169 A2

G970176 A2

The following information presents

the device number, category (in this

case, B), and criterion code.

G910187 B1

G960161 B4

G970014 B2

G970015 B4

G970024 B4

G970045 B4

G970081 B4

G970094 B3

G970096 B1

G970112 B2

G970116 B1

G970117 B4

G970122 B4

G970123 B4

G970129 B2

G970132 B3

G970133 B3

G970134 B4

G970135 B4

G970137 B4

G970138 B4

G970140 B1

G970141 B2

G970142 B1

G970149 B3

G970150 B1

G970157 B4

G970161 B4

G970168 B1

G970178 B2

G970179 B2

G970180 B4

G970183 B1

G970189 B4

G970191 B1

G970193 B2

G970194 B2

[FR Doc. 98–14834 Filed 6–3–98; 8:45 am]

BILLING CODE 4120–01–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Human Genome Research

Institute; Notice of Closed Meetings

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meetings:

Name of Committee: National Human

Genome Research Institute Initial Review

Group, Ethical, Legal, and Social

Implications Subcommittee.

Agenda/Purpose: To review and evaluate

grant applications and/or contract proposals.

Date: June 4, 1998.

Time: 9:00 am–5:00 pm.

Place: Holiday Inn Hotel, Bethesda,

Maryland.

This notice is being published less than

fifteen days prior to the meeting due to the

urgent need to meet timing limitations

imposed by the review and funding cycle.

Name of Committee: National Human

Genome Research Institute, Special Emphasis

Panel 01.

Agenda/Purpose: To review and evaluate

grant applications and/or contract proposals.

Date: June 30, 1998.

Time: 8:30–12 Noon.

Place: Holiday Inn Hotel, Bethesda,

Maryland.

Name of Committee: National Human

Genome Research Institute Initial Review

Group, Genome Research Review

Subcommittee.

Agenda/Purpose: To review and evaluate

grant applications and/or contract proposals.

Date: June 20, 1998.

Time: 1:00–5:00 pm.

Place: Holiday Inn Hotel, Bethesda,

Maryland.

Name of Committee: National Human

Genome Research Institute, Special Emphasis

Panel 02.

Agenda/Purpose: To review and evaluate

grant applications and/or contract proposals.

Date: June 30, 1998.

Time: 8:30 am–5:00 pm.

Place: Holiday Inn Hotel, Bethesda,

Maryland.

Name of Committee: National Human

Genome Research Institute, Special Emphasis

Panel 03.

Agenda/Purpose: To review and evaluate

grant applications and/or contract proposals.

Date: July 1–2, 1998.

Time: 8:30 am–5:00 pm.

Place: Holiday Inn Hotel, Bethesda,

Maryland.
Federal Register / Vol. 63, No. 107 /Thursday, June 4, 1998 / Notices 30507

Contact Person: Rudy Pozzatti, Ph.D.,

Office of Scientific Review, National Human

Genome Research Institute, National

Institutes of Health, Building 38A, Room 604,

Bethesda, Maryland 20892, (301) 402–0838.

The meetings will be closed in accordance

with the provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C. The

applications and/or contract proposals, and

the discussions could reveal confidential

trade secrets or commercial property such as

patentable material, and personal

information concerning individuals

associated with applications, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

(Catalogue of Federal Domestic Assistance

Program No. 93.172, Human Genome

Research)

Dated: May 27, 1998.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 98–14765 Filed 6–3–98; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Allergy and

Infectious Diseases; Notice of Closed

Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

National Institute of Allergy and

Infectious Diseases Special Emphasis

Panel (SEP) meeting:

Name of SEP: Unnate Immunity in

Vertebrates and Insects and Innate Immune

Response to Microbial Infections.

Date: June 26, 1998.

Time: 8:30 a.m. to Adjournment.

Place: Bethesda Ramada Hotel and

Conference Center, Parlor Room, 8400

Wisconsin Avenue, Bethesda, MD 20814,

(301) 496–2550.

Contact Person: Dr. Vassil Georgiev,

Scientific Review Admin., 6003 Executive

Boulevard, Solar Bldg., Room 4C04,

Bethesda, MD 20892, (301) 496–8206.

Purpose/Agenda: To evaluate grant

applications.

The meeting will be closed in accordance

with the provisions set forth in secs.

552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

Applications and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance

Programs Nos. 93.855, Immunology, Allergic

and Immunologic Diseases Research; 93.856,

Microbiology and Infectious Diseases

Research, National Institutes of Health)

Dated: May 27, 1998.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 98–14762 Filed 6–3–98; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Allergy and

Infectious Diseases;

Closed Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

National Institute of Allergy and

Infectious Diseases Special Emphasis

Panel (SEP) meetings:

Name of SEP: Innovative Grant Program for

Approaches in HIV Vaccine Research.

Date: June 15–16, 1998.

Time: 8 a.m. to Adjournment.

Place: Gaithersburg Hilton Hotel,

Gaithersburg-Darnestown Room, 620 Perry

Parkway, Gaithersburg, MD 20877, (301)

977–8900.

Contact Person: Dr. Kevin Ryan, Scientific

Review Adm., 6003 Executive Boulevard,

Solar Bldg., Room 4C12, Bethesda, MD

20892, (301) 496–2550.

Purpose/Agenda: To evaluate grant

applications.

Name of SEP: Immunopathogenesis of

Type 1 Diabetes Mellitus.

Date: July 6–8, 1998.

Time: 8 a.m. to Adjournment.

Place: Bethesda Ramada Hotel,

Ambassador I, 8400 Wisconsin Avenue,

Bethesda, MD 20814, (301) 654–1000.

Contact Person: Dr. Priti Mehrotra,

Scientific Review Adm., 6003 Executive

Boulevard, Solar Bldg., Room 4C14,

Bethesda, MD 20892, (301) 496–2550.

Purpose/Agenda: To evaluate grant

applications.

These meetings will be closed in

accordance with the provisions set forth in

sections 552b(c)(4) and 552b(c)(6), Title 5,

U.S.C. Applications and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance

Programs Nos. 93.855, Immunology, Allergic

and Immunologic Diseases Research; 93.856,

Microbiology and Infectious Diseases

Research, National Institutes of Health)

Dated: May 27, 1998.

LaVerne Y. Stringfield,

Committee Management Officer, National

Institutes of Health.

[FR Doc. 98–14763 Filed 6–3–98; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Mental Health;

Closed Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meetings of the National Institute of

Mental Health Special Emphasis Panel:

Agenda/Purpose: To review and evaluate

grant applications.

Committee Name: National Institute of

Mental Health Special Emphasis Panel.

Date: July 2, 1998.

Time: 1:30 p.m.

Place: Parklawn, Room 9C–18, 5600

Fishers Lane, Rockville, MD 20857.

Contact Person: W. Gregory Zimmerman,

Parklawn, Room 9C–18, 5600 Fishers Lane,

Rockville, MD 20857; Telephone: 301 443–

1340.

Committee Name: National Institute of

Mental Health Special Emphasis Panel.

Date: July 2, 1998.

Time: 11 a.m.

Place: Parklawn, Room 9C–18, 5600

Fishers Lane, Rockville, MD 20857.

Contact Person: W. Gregory Zimmerman,

Parklawn, Room 9C–18, 5600 Fishers Lane,

Rockville, MD 20857; Telephone: 301 443–

1340.

Committee Name: National Institute of

Mental Health Special Emphasis Panel.

Date: July 8, 1998.

Time: 1:30 p.m.

Place: Parklawn, Room 9C–18, 5600

Fishers Lane, Rockville, MD 20857.

Contact Person: W. Gregory Zimmerman,

Parklawn, Room 9C–18, 5600 Fishers Lane,

Rockville, MD 20857; Telephone: 301 443–

1340.

Committee Name: National Institute of

Mental Health Special Emphasis Panel.

Date: July 23, 1998.

Time: 8:30 a.m.

Place: Chevy Chase Holiday Inn, 5520

Wisconsin Avenue, Chevy Chase, MD 20815.

Contact Person: W. Gregory Zimmerman,

Parklawn, Room 9C–18, 5600 Fishers Lane,

Rockville, MD 20857; Telephone: 301 443–

1340.

The meeting will be closed in accordance

with the provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

Applications and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance

Program Numbers 93.242, 93.281, 93.282)